Phase I study of vandetanib with radiation therapy with or without cisplatin in locally advanced head and neck squamous cell carcinoma.

Papadimitrakopoulou, V. A.,Frank, S. J.,Cohen, E. W.,Hirsch, F. R.,Myers, J. N.,Heymach, J. V.,Lin, H.,Tran, H. T.,Chen, C. R.,Jimeno, A.,Nedzi, L.,Vasselli, J. R.,Low...; Head Neck. 2014 Oct 30.

Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma.

Ney, D. E.,Carlson, J. A.,Damek, D. M.,Gaspar, L. E.,Kavanagh, B. D.,Kleinschmidt-DeMasters, B. K.,Waziri, A. E.,Lillehei, K. O.,Reddy, K.,Chen, C.; J. Neurooncol.. 2014 Dec 20.

Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme.

Reddy, K.,Gaspar, L. E.,Kavanagh, B. D.,Chen, C.; J Med Imaging Radiat Oncol. 2014 Jul 01.